TWO SIGMA INVESTMENTS, LP - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$625,000
+97.2%
127,094
+6.7%
0.00%0.0%
Q2 2020$317,000
-8.9%
119,071
-33.3%
0.00%
-33.3%
Q1 2020$348,000
+96.6%
178,650
+610.3%
0.00%
+200.0%
Q4 2019$177,000
-76.5%
25,152
-66.5%
0.00%
-50.0%
Q1 2019$753,00075,0220.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$24,743,0002.02%
Kamunting Street Capital Management, L.P. 345$2,046,0001.28%
DELTEC ASSET MANAGEMENT LLC 853,132$5,059,0000.90%
Alpine Global Management, LLC 552,856$3,278,0000.68%
Kamunting Street Capital Management, L.P. 100,000$593,0000.37%
Redmile Group, LLC 2,397,441$14,217,0000.26%
IHT Wealth Management, LLC 207,210$1,229,0000.12%
ArrowMark Colorado Holdings LLC 2,075,387$12,307,0000.12%
GPS Wealth Strategies Group, LLC 45,500$270,0000.11%
683 Capital Management, LLC 233,600$1,385,0000.10%
View complete list of XERIS PHARMACEUTICALS INC shareholders